【発明の名称】マトリックスメタロプロテアーゼ阻害剤としての置換されたオキシ酪酸

Title:

【発明の名称】マトリックスメタロプロテアーゼ阻害剤としての置換されたオキシ酪酸

Document Type and Number:

Japanese Patent JPH11509870

Kind Code:

A

Abstract:

The present invention provides pharmaceutical compositions and methods for treating certain conditions comprising administering an amount of a compound or composition of the invention which is effective to inhibit the activity of at least one matrix metalloprotease, resulting in achievement of the desired effect. The compounds of the present invention are either of generalized formula (I) wherein y is 0, 2, or 3, r is 0-6, Z is (CH2)7 or (CH2)e-C6H4-(CH2)f, wherein e is 0-1 and f is 1-6, and R<15> is -H, -Cl, -OMe or (a), (b) wherein n is 0-4, R<17> is C2H5, allyl, benzyl, and R<16> is (c) wherein t is 0-1, x is 0-4, and R<4> is one of the following: halide, alkyl of 1-6 carbons, OR, NR2, NO2 (R = H or alkyl of 1-6 carbons). These compounds are useful for inhibiting matrix metalloproteases and, therefore, combating conditions to which MMP's contribute, such as osteoarthritis, rheumatoid arthritis, septic arthritis, periodontal disease, corneal ulceration, proteinuria, aneurysmal aortic disease, dystrophobic epidermolysis, bullosa, conditions leading to inflammatory responses, osteopenias mediated by MMP activity, tempero mandibular joint disease, demyelating diseases of the nervous system, tumor metastasis or degenerative cartilage loss following traumatic joint injury, and coronary thrombosis from atherosclerotic plaque rupture. The present invention also provides pharmaceutical compositions and methods for treating such conditions.

More Like This:

WO/2004/082698	QUATERNARY CHELIDONINE AND ALKALOID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MANUFACTURE OF MEDICAMENTS
JP4499209	Obesity prevention and improvement agent
JP2004527578	Use of NF-κB inhibitors to treat dry eye disorders

Inventors:

Brian Earl Dickson
Jinshan Chen
Michael van zand
David Earl Bittery

Application Number:

JP54100297A

Publication Date:

August 31, 1999

Filing Date:

May 12, 1997

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Bayer Corporation

International Classes:

A61K31/00; A61K31/19; A61K31/403; A61K31/4035; A61P1/00; A61K31/40; A61P1/02; A61P7/00; A61P7/02; A61P13/00; A61P13/02; A61P15/00; A61P19/00; A61P19/02; A61P21/00; A61P27/00; A61P27/02; A61P29/00; A61P35/00; A61P35/04; A61P43/00; C07C59/90; C07D209/48; C07D253/08; (IPC1-7): C07C59/90; A61K31/00; A61K31/19; A61K31/40; C07D209/48

Attorney, Agent or Firm:

Toshio Yano (2 outside)

Previous Patent: ネイルエナメル組成物

Next Patent: カルバペネム系抗生物質、組成物及び調製方法